|
EP2427479A4
(en)
|
|
Antibodies and methods of use thereof
|
|
BRPI1009455A2
(en)
|
|
anti-c40 antibodies and uses thereof
|
|
BRPI1012676A2
(en)
|
|
anti-fcrh5 and immunoconjugate antibodies and methods of use
|
|
BRPI1012560A2
(en)
|
|
anti-fcrh5 and immunoconjugate antibodies and methods of use
|
|
DK3333188T3
(en)
|
|
Anti-NGF antibodies and their use
|
|
BR112012017441A2
(en)
|
|
compounds and methods
|
|
BRPI1008029A2
(en)
|
|
display device and method of manufacture thereof
|
|
BR112013007499A2
(en)
|
|
pyridazinones - rearing methods and uses
|
|
BR112012027159A2
(en)
|
|
structure and method
|
|
HK1182117A1
(en)
|
|
Anti-tenascin-c a2 antibodies and methods of use -c a2
|
|
IL215795A0
(en)
|
|
Anti-il-17f antibodies and methods of use thereof
|
|
BR112012031686A2
(en)
|
|
valve core and valve
|
|
BR112014002716A2
(en)
|
|
anti-polyubiquitin antibodies and methods of use
|
|
BR112014006291A2
(en)
|
|
composition and use of composition
|
|
FI20095529A0
(en)
|
|
New use of probiotics
|
|
IL229631A0
(en)
|
|
Lysyl oxidase-like2 assay and methods of use thereof
|
|
BR112014005660A2
(en)
|
|
coated implants and related methods
|
|
BR112013002544A2
(en)
|
|
closet and closet section
|
|
EP2748615A4
(en)
|
|
Development and use of fluorescent probes of unbound bilirubin
|
|
EP2558496A4
(en)
|
|
Anti-polyubiquitin antibodies and methods of use
|
|
ZA201300174B
(en)
|
|
Anti-neuropilin antibodies and methods of use
|
|
CU24148B1
(en)
|
|
AGOMELATIN INTERMEDIATES AND METHOD OF PREPARATION OF THESE
|
|
FI20095464A
(en)
|
|
Method and method of cleaning
|
|
BR112013008812A2
(en)
|
|
composition and method
|
|
BR112012029669A2
(en)
|
|
composition and method
|